ASX:CGS (Australia)
Business Description
Cogstate Ltd
SIC : 8099
425 Smith Street, Suite 117, Fitzroy, VIC, AUS, 3065
Description
Cogstate Ltd is a cognitive science company. The principal activity of the company is the sale of technology and services for the measurement of cognition, where services include scientific consultancy, project management, data management, statistical analysis, and reporting. Its operating segment includes Clinical Trials; Healthcare and Research. The company generates maximum revenue from the Clinical Trials segment. In the clinical trials segment, technology and services are sold to pharmaceutical and biotechnology companies. The company derives revenue from the sale of licensed software and cognitive testing services.
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 11.65 | |||||
Equity-to-Asset | 0.54 | |||||
Debt-to-Equity | 0.08 | |||||
Debt-to-EBITDA | 0.15 | |||||
Interest Coverage | 118.51 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 5.91 | |||||
Beneish M-Score | -3.31 | |||||
WACC vs ROIC |
Growth Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -9.7 | |||||
3-Year EBITDA Growth Rate | 83.7 | |||||
3-Year Book Growth Rate | 7.3 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 37.12 | |||||
9-Day RSI | 47.39 | |||||
14-Day RSI | 51.54 | |||||
6-1 Month Momentum % | -13.76 | |||||
12-1 Month Momentum % | -2.4 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.4 | |||||
Quick Ratio | 2.4 | |||||
Cash Ratio | 1.63 | |||||
Days Sales Outstanding | 66.03 | |||||
Days Payable | 122.37 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -14 |
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 60.07 | |||||
Operating Margin % | 21.66 | |||||
Net Margin % | 23.88 | |||||
ROE % | 44.61 | |||||
ROA % | 19.46 | |||||
ROIC % | 26.28 | |||||
ROC (Joel Greenblatt) % | 450.52 | |||||
ROCE % | 38.33 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 24.32 | |||||
Forward PE Ratio | 23.58 | |||||
PE Ratio without NRI | 24.32 | |||||
Price-to-Owner-Earnings | 46.15 | |||||
PS Ratio | 6.25 | |||||
PB Ratio | 7.93 | |||||
Price-to-Tangible-Book | 11.06 | |||||
Price-to-Free-Cash-Flow | 120 | |||||
Price-to-Operating-Cash-Flow | 62.07 | |||||
EV-to-EBIT | 16.66 | |||||
EV-to-Forward-EBIT | 14.54 | |||||
EV-to-EBITDA | 13.99 | |||||
EV-to-Forward-EBITDA | 12.33 | |||||
EV-to-Revenue | 5.08 | |||||
EV-to-Forward-Revenue | 3.44 | |||||
EV-to-FCF | 95.44 | |||||
Price-to-Projected-FCF | 10.41 | |||||
Price-to-Median-PS-Value | 3.34 | |||||
Price-to-Graham-Number | 3.47 | |||||
Price-to-Net-Current-Asset-Value | 16.09 | |||||
Price-to-Net-Cash | 177 | |||||
Earnings Yield (Greenblatt) % | 6.01 |
Guru Trades
See DetailsEMBED
SAVE
Insider Trades
See DetailsEMBED
SAVE
Executives
EMBED
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil A$) | 55.018 | ||
EPS (TTM) (A$) | 0.074 | ||
Beta | 1.15 | ||
Volatility % | 60.51 | ||
14-Day RSI | 51.54 | ||
14-Day ATR (A$) | 0.09179 | ||
20-Day SMA (A$) | 1.8055 | ||
12-1 Month Momentum % | -2.4 | ||
52-Week Range (A$) | 1.355 - 2.68 | ||
Shares Outstanding (Mil) | 173.37 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 7 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Cogstate Ltd Filings
Document | Form | Filing Date | ||
---|---|---|---|---|
No Filing Data |